Why the smallpox vaccine to be manufactured in Germany by Bavarian Nordic was purchased through an intermediary rather than directly. [HL 4591].

Why the smallpox vaccine to be manufactured in Germany by Bavarian Nordic was purchased through an intermediary rather than directly. [HL 4591].

Which pharmaceutical companies they approached about the purchase of smallpox vaccine; and whether those companies included Bavarian Nordic [HL 3923].

Which pharmaceutical companies they approached about the purchase of smallpox vaccine; and whether those companies included Bavarian Nordic [HL 3923].

Whether they considered the use of the accelerated tendering procedures permitted by European Union procurement rules for the purchase of smallpox vaccines; and, if so, why those procedures were not adopted [HL 3979].

Whether they considered the use of the accelerated tendering procedures permitted by European Union procurement rules for the purchase of smallpox vaccines; and, if so, why those procedures were not adopted [HL 3979].

Further to the statement by Lord Hunt of Kings Heath that the procurement of smallpox vaccines fell outside the usual rules governing competitive tendering because the procurement concerns national security (18 April, 633 c1075), whether they regard the announcement by PowderJect Pharmaceuticals that it had been awarded a contract for...

Further to the statement by Lord Hunt of Kings Heath that the procurement of smallpox vaccines fell outside the usual rules governing competitive tendering because the procurement concerns national security (18 April, 633 c1075), whether they regard the announcement by PowderJect Pharmaceuticals that it had been awarded a contract for...

Whether the smallpox vaccine to be supplied by PowderJect Ltd will be produced in the United Kingdom [HL 3988].

Whether the smallpox vaccine to be supplied by PowderJect Ltd will be produced in the United Kingdom [HL 3988].

Whether, when they awarded the contract for smallpox vaccine to PowderJect Pharmaceuticals, they were aware that the company did not intend to manufacture the vaccine itself; and whether they approved the plan to sub-contract manufacture to Bavarian Nordic. [HL 3922].

Whether, when they awarded the contract for smallpox vaccine to PowderJect Pharmaceuticals, they were aware that the company did not intend to manufacture the vaccine itself; and whether they approved the plan to sub-contract manufacture to Bavarian Nordic. [HL 3922].

What was meant by the Prime Minister's statement, 383 c567, 17 April 2002, that "many companies were asked to tender" for the smallpox vaccine contract. [HL 3924].

What was meant by the Prime Minister's statement, 383 c567, 17 April 2002, that "many companies were asked to tender" for the smallpox vaccine contract. [HL 3924].

Whether they will be meeting the costs of clinical trials for smallpox vaccine to be supplied by PowderJect Pharmaceuticals; and, if so, how much these are expected to cost. [HL 3925].

Whether they will be meeting the costs of clinical trials for smallpox vaccine to be supplied by PowderJect Pharmaceuticals; and, if so, how much these are expected to cost. [HL 3925].

What previous government contracts have been awarded to PowderJect Pharmaceuticals; and what have been the outcomes of those contracts. [HL 3885].

What previous government contracts have been awarded to PowderJect Pharmaceuticals; and what have been the outcomes of those contracts. [HL 3885].

Whether the stockpile of smallpox vaccine which they have purchased from PowderJect Pharmaceuticals is derived from cell lines from aborted foetuses. [HL 3806].

Whether the stockpile of smallpox vaccine which they have purchased from PowderJect Pharmaceuticals is derived from cell lines from aborted foetuses. [HL 3806].